03 November 2023
03 November 2023
The Alinity m HR HPV assay will provide data on 14 different potentially cancer-causing virus genotypes.
Following a 12-month study, the QDOT MICRO device demonstrates its potential to relieve symptoms and improve life quality for patients with atrial fibrillation.
The new device can draw blood samples directly from a patient's peripheral IV line using PIVO Pro.
Avenda’s Unfold AI device, used to map the probability of prostate cancer, has received the temporary designation aimed at tracking emerging treatments.
Empatica received US FDA clearance for remote monitoring of two digital cardiac markers - pulse and respiratory rate.
Co-Diagnostics will use the funding to leverage the manufacturing capabilities of its Indian joint venture, CoSara Diagnostics.
The access catheter is already FDA-cleared for neurovascular access, with the company eyeing expanded clearance for thrombectomy
Toku’s AI software identifies CVD risk from retinal scans, the company is aiming for a mid-2025 US market launch.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
The healthcare, pharma, and medical devices industries are often risk-averse compared to other sectors when adopting new technologies. However, mainly due to COVID-19, these sectors have witnessed an acceleration in digital transformation. AI can revolutionize the drug discovery process and significantly reduce the time and cost to get a drug to market, particularly in areas of unmet need. There is also huge potential for AI in medical diagnostics. However, using healthcare data for AI development raises data privacy concerns, thereby limiting its adoption.
Give your business an edge with our leading industry insights.
